In this issue of Clinics in Perinatology, guest editor Dr. Lina Chalak brings her considerable expertise to the topic of Perinatal Asphyxia:: Moving the Needle. Top experts discuss current clinical information on perinatal asphyxia, giving perinatologists they guidance they need to improve outcomes in newborns, while looking at results from clinical trials, neuroimaging biomarkers, and low-resource settings.
Causes and Terminology in Neonatal Encephalopathy: What is in a Name? Neonatal Encephalopathy, Hypoxic-ischemic Encephalopathy or Perinatal Asphyxia Neonatal Encephalopathy is a Complex Phenotype Representing Reproductive and Pregnancy Exposome Effects on the Maternal-Placental-Fetal Triad Uncovering the Role of Inflammation with Asphyxia in the Newborn Reverse Therapy: Impact of Hyperthermia and Rewarming on Newborn Outcomes Treating Seizures and Improving Newborn Outcomes for Infants with Hypoxic[1]Ischemic Encephalopathy Hypothermia for Hypoxic-ischemic Encephalopathy: Second-generation Trials to Address Gaps in Knowledge A New Horizon for Understanding the Comparative Effectiveness for Cooling Prospectively Infants with Mild Encephalopathy Key Inflammatory Biomarkers in Perinatal Asphyxia: A Comprehensive Review Advances in Neuroimaging Biomarkers and Scoring Advances in Electroencephalographic Biomarkers of Neonatal Hypoxic Ischemic Encephalopathy Moving the Needle in Low-Resource Settings: Is Hypothermia a Friend or a Foe? Long-Term Outcomes Following Hypoxic Ischemic Encephalopathy Communicating with Parents About Therapeutic Hypothermia and Hypoxic Ischemic Encephalopathy: Integrating a Palliative Care Approach into Practice Ethical and Legal Perspectives on the Treatment of Hypoxic Ischemic Encephalopathy in the Newborn Pipeline to Neonatal Clinical Transformation: The Importance of Preclinical Data
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.